Baseline 18F-FDG PET and CT tumor response measurements with PERCIST and EORTC criteria and progression-free survival per patient with ALK positive NSCLC.
收藏数据链接:
官方服务:
资源简介:
Baseline 18F-FDG PET and CT tumor response measurements with PERCIST and EORTC criteria and progression-free survival per patient with ALK positive NSCLC.
创建时间:
2016-05-05




